These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6170552)

  • 1. The influence of cytostatic treatment on the initiation of plasma coagulation in patients with neoplastic diseases.
    Czestochowska E; Tymiński W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):574-9. PubMed ID: 6170552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange.
    Tek I; Arslan O; Arat M; Ozcan M; Akdağ B; Ilhan O
    Transfus Apher Sci; 2003 Feb; 28(1):3-7. PubMed ID: 12620262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation studies in patients with acute leukemia before and after cytostatic chemotherapy].
    Bhaduri S; Rasche H; Köhle W; Dietrich M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1142-4. PubMed ID: 611807
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in hemostasis of dogs with acute lymphoblastic leukemia].
    Mischke R; Freund M; Leinemann-Fink T; Eisenberger B; Casper J; Nolte I
    Berl Munch Tierarztl Wochenschr; 1998 Feb; 111(2):53-9. PubMed ID: 9513298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiologic values of coagulation factors in newborn infants].
    Baklaja R; Cvetković V; Stajić M
    Bilt Hematol Transfuz; 1980; 8(1):29-35. PubMed ID: 7337680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation.
    Ghosh K; Mota L; Shetty S; Kulkarni B
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):577-80. PubMed ID: 18685441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorrhagic diathesis in patients with malignant neoplasms (author's transl)].
    Zöller H; Gross W; Schreiner W
    Med Klin; 1979 Nov; 74(46):1716-20. PubMed ID: 118327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
    Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
    Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of the antihemophilic globulin A (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIII].
    Liebe S
    Z Gesamte Inn Med; 1982 Feb; 37(4):110-6. PubMed ID: 6805144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
    Clyne LP; Honig CL; Dainiak N
    Thromb Haemost; 1984 Jul; 51(3):317-20. PubMed ID: 6437003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of coagulation factors on intrinsic thrombin generation.
    Stief TW; Otto S; Renz H
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):67-71. PubMed ID: 17179830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous administration of T-2 toxin on blood coagulation in calves.
    Gentry PA; Cooper ML
    Am J Vet Res; 1983 May; 44(5):741-6. PubMed ID: 6869975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population.
    Barillari G; Fabbro E; Pasca S; Bigotto E
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):290-6. PubMed ID: 19318924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
    Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.